HomeSONN • NASDAQ
add
Sonnet BioTherapeutics Holdings, Inc.
Previous close
$1.24
Day range
$1.23 - $1.30
Year range
$1.10 - $16.00
Market cap
4.08M USD
Avg Volume
40.00K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 2.34M | 37.81% |
Net income | -3.49M | -1,055.36% |
Net profit margin | — | — |
Earnings per share | -0.89 | -258.93% |
EBITDA | -4.23M | -9.35% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 2.06M | -45.61% |
Total assets | 3.84M | -35.08% |
Total liabilities | 3.17M | 11.17% |
Total equity | 662.26K | — |
Shares outstanding | 3.12M | — |
Price to book | 5.90 | — |
Return on assets | -191.92% | — |
Return on capital | -431.55% | — |
Cash Flow
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -3.49M | -1,055.36% |
Cash from operations | -2.47M | -441.43% |
Cash from investing | -12.00K | — |
Cash from financing | -318.96K | -877.95% |
Net change in cash | -2.80M | -466.40% |
Free cash flow | -1.92M | 7.00% |
About
Founded
1999
Headquarters
Website
Employees
13
